Karo Pharma AB (publ) (KA6N) : Analyse, Valorisation, Dividende et Ratios Financiers

Karo Pharma AB (publ)

KA6NStockF

€—

K

Karo Pharma AB (publ)

€—

KA6NStockF

Arberion© 2026

Arberion

Loading market data